癫痫持续状态

Consultant Neurologist

Greater Manchester Neurosciences Centre

Salford Royal Foundation Trust

UK

简介

MJ is an honorary senior lecturer at the University of Manchester.

利益声明

MJ declares that he has no competing interests.

Neurology Registrar

Manchester Centre for Clinical Neurosciences

Salford Royal NHS Foundation Trust

UK

利益声明

RP has been sponsored by Novartis to attend the International Headache Conference.

BMJ Best Practice would like to gratefully acknowledge the previous team of expert contributors, whose work is retained in parts of the content:

Ronald P. Lesser, MD

Professor of Neurology and Neurosurgery

Johns Hopkins Medical Institutions

Baltimore

MD

Disclosures: RPL's wife holds shares in Abbott Laboratories, which makes Depakote, a brand formulation of valproate/divalproex. RPL holds shares in Abbvie, Express Scripts, Halgene, Halyard Health, Hospira, Johnson and Johnson (which makes Topamax, a brand formulation of topiramate), Merck and Company, and Pfizer (which makes Dilantin and Cerebyx, brand formulations of phenytoin and fosphenytoin, respectively).

Emily Johnson, MD

Assistant Professor of Neurology

Johns Hopkins Medical Institutions

Baltimore

MD

Disclosures: EJ declares that she has no competing interests.

Section Editor, BMJ Best Practice

利益声明

HDC declares that she has no competing interests.

Lead Section Editor, BMJ Best Practice

利益声明

SM works as a freelance medical journalist and editor, video editorial director and presenter, and communications trainer. In this capacity, she has been paid, and continues to be paid, by a wide range of organisations for providing these skills on a professional basis. These include: NHS organisations, including NICE, NHS Choices, NHS Kidney Care, and others; publishers and medical education companies, including the BMJ Group, the Lancet group, Medscape, and others; professional organisations, including the British Thoracic Oncology Group, the European Society for Medical Oncology, NCEPOD, and others; charities and patients’ organisations, including the Roy Castle Lung Cancer Foundation and others; pharmaceutical companies, including Bayer, Boehringer Ingelheim, Novartis, and others; and communications agencies, including Publicis, Red Healthcare, and others. She has no stock options or shares in any pharmaceutical or healthcare companies; however, she invests in a personal pension, which may invest in these types of companies. She is managing director of Susan Mayor Limited, the company name under which she provides medical writing and communications services.

Lead Section Editor, BMJ Best Practice

利益声明

TAO declares that she has no competing interests.

Comorbidities Editor, BMJ Best Practice

利益声明

JC declares that she has no competing interests.

Drug Editor, BMJ Best Practice

利益声明

AM declares that he has no competing interests.